Pembrolizumab-induced psoriatic arthritis treated with disease-modifying anti-rheumatic drugs in a patient with gastric cancer: A case report

doi:10.12998/wjcc.v11.i1.218

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4034)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

266

WORD

HTML

2004

Figures (1-3)

376

Sum=2678

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

170

Download

358

Sum=528

Publishing Process of This Article

Item

Count

Browse

191

Download

637

Sum=828

Jan 6, 2023 (publication date) through Nov 2, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Jan 6, 2023; 11(1): 218-224
Published online Jan 6, 2023. doi: 10.12998/wjcc.v11.i1.218

Full Size Figure Download Figure

Figure 3 Treatment course for psoriatic arthritis and changes in inflammation-related peripheral blood parameters. ESR: Erythrocyte sedimentation rate; DAPSA: Disease activity in psoriatic arthritis; hs-CRP: High-sensitivity C-reactive protein; PNI: Prognostic nutritional index; NLR: Neutrophil-to-lymphocyte ratio.

Citation: Kim S, Sun JH, Kim H, Kim HK, Yang Y, Lee JS, Choi IA, Han HS. Pembrolizumab-induced psoriatic arthritis treated with disease-modifying anti-rheumatic drugs in a patient with gastric cancer: A case report. World J Clin Cases 2023; 11(1): 218-224
URL: https://www.wjgnet.com/2307-8960/full/v11/i1/218.htm
DOI: https://dx.doi.org/10.12998/wjcc.v11.i1.218